Skip to content

Carisbamate

DRUG12 trials

Sponsors

Sk Life Science Inc., SK Life Science, Inc., Baylor College of Medicine

Conditions

Alcohol AbuseAlcohol DependenceComplex Partial SeizuresEpilepsies, PartialEpilepsyEpilepsy, Complex PartialEpilepsy, Partial, MotorEpilepsy, Simple Partial

Phase 1

Phase 2

Phase 3

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.
TerminatedNCT00563459
SK Life Science, Inc.Epilepsy, Seizures
Start: 2007-11-30End: 2010-04-30Updated: 2013-01-29
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
CompletedNCT00740623
SK Life Science, Inc.Epilepsy, Complex Partial, Epilepsy, Partial, Motor, Epilepsy, Simple Partial +1
Start: 2009-01-31End: 2010-04-30Updated: 2013-01-24
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
CompletedNCT00744731
SK Life Science, Inc.Epilepsy, Complex Partial, Epilepsy, Partial, Motor, Epilepsy, Simple Partial +1
Start: 2009-01-31End: 2010-08-31Updated: 2013-06-18
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
CompletedNCT00991757
SK Life Science, Inc.Complex Partial Seizures, Epilepsies, Partial, Epilepsy +1
Start: 2007-02-28End: 2010-10-31Updated: 2013-06-18
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
RecruitingNCT05219617
SK Life Science, Inc.Lennox Gastaut Syndrome, Seizures
Start: 2022-04-28End: 2028-12-31Target: 252Updated: 2025-07-24
A Randomized, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults, with Optional Open- Label Extension
RecruitingCTIS2023-506616-41-00
Sk Life Science Inc.Lennox-Gastaut syndrome (LGS)
Start: 2023-03-31Target: 92Updated: 2025-11-14